Elbasvir: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Elbasvir. Educational only — not medical advice.
Labeled uses
ZEPATIER® is indicated for the treatment of chronic hepatitis C virus (HCV) genotype 1 or 4 infection in adult and pediatric patients 12 years of age and older or weighing at least 30 kg. ZEPATIER is indicated for use with ribavirin in certain patient populations [see Dosage and Administration (2.2) ] .
Source: FDA labeling via NIH DailyMed (set 164dc02a…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.